FIELD: medicine. SUBSTANCE: method involves administering 2-3 sessions of discrete plasmapheresis in succession with 30-50% of circulating plasma being discharged and substituted with plasma-substituting solutions containing 6 or 10% of hydroxyethylated starch. EFFECT: enhanced effectiveness of treatment; no danger of allergic adverse consequences in pregnant women.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING SEVERE GESTOSIS FORMS | 2003 |
|
RU2259568C2 |
| METHOD FOR INTERRUPTING PREGNANCY AT THE SECOND TRIMESTER IN CASES OF LACK OF AMNIOTIC FLUID | 1995 |
|
RU2124326C1 |
| METHOD OF APPLYING AUTOPLASMODONORSHIP AND ACUTE NORMOVOLEMIC HEMODILUTION IN CASE OF ABDOMINAL LABOUR | 2009 |
|
RU2410129C1 |
| METHOD FOR STIMULATING OVULATION IN CASES OF OLIGOMENORRHEA AND CHRONIC SALPINGO-OOPHORITIS | 1996 |
|
RU2129444C1 |
| PRECLINICAL METHOD FOR DIAGNOSING THE CASES OF GESTOSIS | 1998 |
|
RU2135999C1 |
| METHOD FOR DETECTING BLOOD LOSS AT CAESAREAN OPERATION | 2002 |
|
RU2239351C2 |
| METHOD FOR TREATING ENDOMETRITIS AFTER APPLYING INTRAUTERINE CONTRACEPTION MEANS | 1998 |
|
RU2160136C2 |
| METHOD TO TREAT OVARIAN HYPERSTIMULATION SYNDROME IN INFERTILE FEMALES | 1994 |
|
RU2103931C1 |
| METHOD FOR PROPHYLAXIS OF PREGNANCY GESTOSIS | 2005 |
|
RU2281774C1 |
| METHOD OF PREVENTING INFLAMMATORY AND THROMBOEMBOLIC COMPLICATIONS AFTER CESAREAN SECTION OPERATION IN WOMEN FROM HIGH RISK GROUP | 2009 |
|
RU2418595C1 |
